Metabolism of valproate to hepatotoxic intermediates

This publication has 34 references indexed in Scilit:

• The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1990
• Studies of the inactivation of general acyl-CoA dehydrogenase by racemic (methylenecyclopropane)acetyl-CoA-new evidence suggesting a radical mechanism of this enzyme catalyzed reaction
  Journal of the American Chemical Society, 1989
• Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid
  Biochemical and Biophysical Research Communications, 1985
• A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: Possible clinical significance
  Life Sciences, 1985
• The Toxicity of Metabolites of Sodium Valproate in Cultured Hepatocytes
  The Journal of Clinical Pharmacology, 1983
• Valproate–Induced Hepatic Steatogenesis in Rats
  Hepatology, 1982
• Sodium Valproate in the Induction of Unusual Hepatotoxicity
  Hepatology, 1982
• INHIBITION OF FATTY ACID OXIDATION BY VALPROATE
  The Lancet, 1980
• Reye-like syndrome associated with valproic acid therapy
  The Journal of Pediatrics, 1979
• Metabolism of branched medium chain length fatty acid. II—β-oxidation of sodium dipropylacetate in rats
  Journal of Mass Spectrometry, 1976